PlainRecalls
FDA Drug Moderate Class II Terminated

Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India ---- NDC 68180-0124-02

Reported: January 23, 2019 Initiated: January 7, 2019 #D-0380-2019

Product Description

Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India ---- NDC 68180-0124-02

Reason for Recall

CGMP Deviation; manufacturing batch record could not be located

Details

Units Affected
7,215 bottles
Distribution
Product was distributed to 12 major distributors who may have further distributed the product throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India ---- NDC 68180-0124-02. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 7,215 bottles.
Why was this product recalled?
CGMP Deviation; manufacturing batch record could not be located
Which agency issued this recall?
This recall was issued by the FDA Drug on January 23, 2019. Severity: Moderate. Recall number: D-0380-2019.